Charles Schwab’s General Moly, Inc. GMO Stock Holding History

Charles Schwab’s Portfolio GMO Stock Details GMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,700	Closed	-$6K	–	3055
2016 Q2	$6K	Hold	15,700	–	–	﹤0.01%	3102
2016 Q1	$6K	Hold	15,700	–	–	﹤0.01%	3059
2015 Q4	$4K	Hold	15,700	–	–	﹤0.01%	3100
2015 Q3	$5K	Hold	15,700	–	–	﹤0.01%	3090
2015 Q2	$12K	Hold	15,700	–	–	﹤0.01%	3088
2015 Q1	$9K	Hold	15,700	–	–	﹤0.01%	3080
2014 Q4	$9K	Hold	15,700	–	–	﹤0.01%	3107
2014 Q3	$12K	Hold	15,700	–	–	﹤0.01%	3071
2014 Q2	$19K	Sell	15,700 -90,300	-85%	-$94.2K	﹤0.01%	3085
2014 Q1	$105K	Hold	106,000	–	–	﹤0.01%	3036
2013 Q4	$143K	Hold	106,000	–	–	﹤0.01%	3029
2013 Q3	$173K	Sell	106,000 -38,744	-27%	-$69.9K	﹤0.01%	2960
2013 Q2	$274K	Buy	+144,744	New	+$285K	﹤0.01%	2761

Other funds holding GMO

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

FIM

Fernwood Investment Management Quincy, Massachusetts $288M AUM 33.54% 1-Year Est. Return

Charles Schwab's GMO Position: Q3 2016 in Review

Charles Schwab sold out of General Moly, Inc. (GMO) in Q3 2016, closing a stake of 15,700 shares — an estimated $6K sold.

Charles Schwab first reported a position in GMO in Q2 2013 and held it in 13 quarters. The position peaked at $274K in Q2 2013. 36 funds tracked by Wall St. Rank hold GMO as of Q3 2016.

Charles Schwab reported no remaining General Moly, Inc. position as of Q3 2016 after selling out during the quarter.
Charles Schwab sold 15,700 General Moly, Inc. shares in Q3 2016, an estimated $6K.
Charles Schwab first reported a position in General Moly, Inc. in Q2 2013 and held it in 13 quarters.
Charles Schwab's General Moly, Inc. position peaked at $274K in Q2 2013.
36 funds tracked by Wall St. Rank held General Moly, Inc. as of Q3 2016.

Based on Charles Schwab's 13F filing for Q3 2016, filed 14 Nov 2016.